A comparison of the stability of doxorubicin and daunorubicin in solid state
The degradation of doxorubicin and daunorubcin in the solid state was studied using an HPLC method with UV detection (LiChrospher RP-18, 5 μm, 250 mm × 4 mm; mobile phase: acetonitrile-solution A 1:1, v/v (solution A: 2.88 g of laurisulfate sodium and 1.6 ml of phosphoric acid(V) in 1000 ml); flow r...
Gespeichert in:
Veröffentlicht in: | Journal of pharmaceutical and biomedical analysis 2009-11, Vol.50 (4), p.576-579 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 579 |
---|---|
container_issue | 4 |
container_start_page | 576 |
container_title | Journal of pharmaceutical and biomedical analysis |
container_volume | 50 |
creator | Cielecka-Piontek, J. Jelińska, A. Zając, M. Sobczak, M. Bartold, A. Oszczapowicz, I. |
description | The degradation of doxorubicin and daunorubcin in the solid state was studied using an HPLC method with UV detection (LiChrospher RP-18, 5
μm, 250
mm
×
4
mm; mobile phase: acetonitrile-solution A 1:1, v/v (solution A: 2.88
g of laurisulfate sodium and 1.6
ml of phosphoric acid(V) in 1000
ml); flow rate – 1.4
ml
min
−1; UV detection – 254
nm). The degradation of doxorubicin was a first-order reaction depending on the substrate concentration and daunorubicin degraded according to the kinetic model of autocatalysis. The dependence ln
k
i
=
f(1/
T) was described by the equations ln
k
DOX
=
40.0
±
15.6
–
(19804
±
5682) (1/
T) and ln
k
DAU
=
35.9
±
11.3
–
(16581
±
3972) (1/
T) at 76.4% RH. The dependence ln
k
i
=
f(RH%) was described by the equations ln
k
DOX
=
(8.80
±
3.60)
×
10
−2 (RH%)
–
(21.50
±
2.57) and ln
k
DAU
=
(6.63
±
1.22)
×
10
−2 (RH%)
–
(13.35
±
1.68). The thermodynamic parameters (
E
a, Δ
H
≠a
, Δ
S
≠a
) of the degradation of doxorubicin and daunorubicin were calculated. Although the degradation of doxorubicin was slower at increased temperature (353–373
K) and relative air humidity (50.9–90.0%), the differences between the influence of temperature and relative air humidity on the stability doxorubicin and of daunorubicin were not significant. |
doi_str_mv | 10.1016/j.jpba.2008.12.029 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733574570</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0731708508006560</els_id><sourcerecordid>733574570</sourcerecordid><originalsourceid>FETCH-LOGICAL-c385t-789251c794431ff1d337cf73bf98cce26d230281b487c50c96b8dec387eba4273</originalsourceid><addsrcrecordid>eNp9kE1LxDAQhoMo7rr6BzxIL-KpNZO0TQJeZPELFrwoeAtpkmKWbrMmrbj_3pYt600YGBie92V4ELoEnAGG8nadrbeVygjGPAOSYSKO0Bw4oykp849jNMeMQsowL2boLMY1xrgAkZ-iGQgQBQeYo9V9ov1mq4KLvk18nXSfNomdqlzjut14MP7Hh75y2rWJak1iVN8eDsNE3zgzRjp7jk5q1UR7Me0Fen98eFs-p6vXp5fl_SrVlBddyrggBWgm8pxCXYOhlOma0aoWXGtLSkMoJhyqnDNdYC3Kihs7ZJmtVE4YXaCbfe82-K_exk5uXNS2aVRrfR8lo7RgecHwQJI9qYOPMdhaboPbqLCTgOUoUa7lKFGOEiUQOUgcQldTfV9trPmLTNYG4HoCVNSqqYNqtYsHjoBgouR84O72nB1kfDsbZNTOttoaF6zupPHuvz9-Af_mj5s</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733574570</pqid></control><display><type>article</type><title>A comparison of the stability of doxorubicin and daunorubicin in solid state</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Cielecka-Piontek, J. ; Jelińska, A. ; Zając, M. ; Sobczak, M. ; Bartold, A. ; Oszczapowicz, I.</creator><creatorcontrib>Cielecka-Piontek, J. ; Jelińska, A. ; Zając, M. ; Sobczak, M. ; Bartold, A. ; Oszczapowicz, I.</creatorcontrib><description>The degradation of doxorubicin and daunorubcin in the solid state was studied using an HPLC method with UV detection (LiChrospher RP-18, 5
μm, 250
mm
×
4
mm; mobile phase: acetonitrile-solution A 1:1, v/v (solution A: 2.88
g of laurisulfate sodium and 1.6
ml of phosphoric acid(V) in 1000
ml); flow rate – 1.4
ml
min
−1; UV detection – 254
nm). The degradation of doxorubicin was a first-order reaction depending on the substrate concentration and daunorubicin degraded according to the kinetic model of autocatalysis. The dependence ln
k
i
=
f(1/
T) was described by the equations ln
k
DOX
=
40.0
±
15.6
–
(19804
±
5682) (1/
T) and ln
k
DAU
=
35.9
±
11.3
–
(16581
±
3972) (1/
T) at 76.4% RH. The dependence ln
k
i
=
f(RH%) was described by the equations ln
k
DOX
=
(8.80
±
3.60)
×
10
−2 (RH%)
–
(21.50
±
2.57) and ln
k
DAU
=
(6.63
±
1.22)
×
10
−2 (RH%)
–
(13.35
±
1.68). The thermodynamic parameters (
E
a, Δ
H
≠a
, Δ
S
≠a
) of the degradation of doxorubicin and daunorubicin were calculated. Although the degradation of doxorubicin was slower at increased temperature (353–373
K) and relative air humidity (50.9–90.0%), the differences between the influence of temperature and relative air humidity on the stability doxorubicin and of daunorubicin were not significant.</description><identifier>ISSN: 0731-7085</identifier><identifier>EISSN: 1873-264X</identifier><identifier>DOI: 10.1016/j.jpba.2008.12.029</identifier><identifier>PMID: 19195811</identifier><identifier>CODEN: JPBADA</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Analysis ; Analytical, structural and metabolic biochemistry ; Antibiotics, Antineoplastic - chemistry ; Biological and medical sciences ; Chromatography, High Pressure Liquid - methods ; Daunorubicin ; Daunorubicin - chemistry ; Doxorubicin ; Doxorubicin - chemistry ; Drug Stability ; Fundamental and applied biological sciences. Psychology ; General pharmacology ; HPLC ; Humidity ; Kinetics ; Medical sciences ; Pharmacology. Drug treatments ; Solid State ; Spectrophotometry, Ultraviolet - methods ; Stability ; Temperature ; Thermodynamics</subject><ispartof>Journal of pharmaceutical and biomedical analysis, 2009-11, Vol.50 (4), p.576-579</ispartof><rights>2008 Elsevier B.V.</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c385t-789251c794431ff1d337cf73bf98cce26d230281b487c50c96b8dec387eba4273</citedby><cites>FETCH-LOGICAL-c385t-789251c794431ff1d337cf73bf98cce26d230281b487c50c96b8dec387eba4273</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0731708508006560$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>309,310,314,776,780,785,786,3537,23909,23910,25118,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21979688$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19195811$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cielecka-Piontek, J.</creatorcontrib><creatorcontrib>Jelińska, A.</creatorcontrib><creatorcontrib>Zając, M.</creatorcontrib><creatorcontrib>Sobczak, M.</creatorcontrib><creatorcontrib>Bartold, A.</creatorcontrib><creatorcontrib>Oszczapowicz, I.</creatorcontrib><title>A comparison of the stability of doxorubicin and daunorubicin in solid state</title><title>Journal of pharmaceutical and biomedical analysis</title><addtitle>J Pharm Biomed Anal</addtitle><description>The degradation of doxorubicin and daunorubcin in the solid state was studied using an HPLC method with UV detection (LiChrospher RP-18, 5
μm, 250
mm
×
4
mm; mobile phase: acetonitrile-solution A 1:1, v/v (solution A: 2.88
g of laurisulfate sodium and 1.6
ml of phosphoric acid(V) in 1000
ml); flow rate – 1.4
ml
min
−1; UV detection – 254
nm). The degradation of doxorubicin was a first-order reaction depending on the substrate concentration and daunorubicin degraded according to the kinetic model of autocatalysis. The dependence ln
k
i
=
f(1/
T) was described by the equations ln
k
DOX
=
40.0
±
15.6
–
(19804
±
5682) (1/
T) and ln
k
DAU
=
35.9
±
11.3
–
(16581
±
3972) (1/
T) at 76.4% RH. The dependence ln
k
i
=
f(RH%) was described by the equations ln
k
DOX
=
(8.80
±
3.60)
×
10
−2 (RH%)
–
(21.50
±
2.57) and ln
k
DAU
=
(6.63
±
1.22)
×
10
−2 (RH%)
–
(13.35
±
1.68). The thermodynamic parameters (
E
a, Δ
H
≠a
, Δ
S
≠a
) of the degradation of doxorubicin and daunorubicin were calculated. Although the degradation of doxorubicin was slower at increased temperature (353–373
K) and relative air humidity (50.9–90.0%), the differences between the influence of temperature and relative air humidity on the stability doxorubicin and of daunorubicin were not significant.</description><subject>Analysis</subject><subject>Analytical, structural and metabolic biochemistry</subject><subject>Antibiotics, Antineoplastic - chemistry</subject><subject>Biological and medical sciences</subject><subject>Chromatography, High Pressure Liquid - methods</subject><subject>Daunorubicin</subject><subject>Daunorubicin - chemistry</subject><subject>Doxorubicin</subject><subject>Doxorubicin - chemistry</subject><subject>Drug Stability</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>General pharmacology</subject><subject>HPLC</subject><subject>Humidity</subject><subject>Kinetics</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Solid State</subject><subject>Spectrophotometry, Ultraviolet - methods</subject><subject>Stability</subject><subject>Temperature</subject><subject>Thermodynamics</subject><issn>0731-7085</issn><issn>1873-264X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LxDAQhoMo7rr6BzxIL-KpNZO0TQJeZPELFrwoeAtpkmKWbrMmrbj_3pYt600YGBie92V4ELoEnAGG8nadrbeVygjGPAOSYSKO0Bw4oykp849jNMeMQsowL2boLMY1xrgAkZ-iGQgQBQeYo9V9ov1mq4KLvk18nXSfNomdqlzjut14MP7Hh75y2rWJak1iVN8eDsNE3zgzRjp7jk5q1UR7Me0Fen98eFs-p6vXp5fl_SrVlBddyrggBWgm8pxCXYOhlOma0aoWXGtLSkMoJhyqnDNdYC3Kihs7ZJmtVE4YXaCbfe82-K_exk5uXNS2aVRrfR8lo7RgecHwQJI9qYOPMdhaboPbqLCTgOUoUa7lKFGOEiUQOUgcQldTfV9trPmLTNYG4HoCVNSqqYNqtYsHjoBgouR84O72nB1kfDsbZNTOttoaF6zupPHuvz9-Af_mj5s</recordid><startdate>20091101</startdate><enddate>20091101</enddate><creator>Cielecka-Piontek, J.</creator><creator>Jelińska, A.</creator><creator>Zając, M.</creator><creator>Sobczak, M.</creator><creator>Bartold, A.</creator><creator>Oszczapowicz, I.</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20091101</creationdate><title>A comparison of the stability of doxorubicin and daunorubicin in solid state</title><author>Cielecka-Piontek, J. ; Jelińska, A. ; Zając, M. ; Sobczak, M. ; Bartold, A. ; Oszczapowicz, I.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c385t-789251c794431ff1d337cf73bf98cce26d230281b487c50c96b8dec387eba4273</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Analysis</topic><topic>Analytical, structural and metabolic biochemistry</topic><topic>Antibiotics, Antineoplastic - chemistry</topic><topic>Biological and medical sciences</topic><topic>Chromatography, High Pressure Liquid - methods</topic><topic>Daunorubicin</topic><topic>Daunorubicin - chemistry</topic><topic>Doxorubicin</topic><topic>Doxorubicin - chemistry</topic><topic>Drug Stability</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>General pharmacology</topic><topic>HPLC</topic><topic>Humidity</topic><topic>Kinetics</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Solid State</topic><topic>Spectrophotometry, Ultraviolet - methods</topic><topic>Stability</topic><topic>Temperature</topic><topic>Thermodynamics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cielecka-Piontek, J.</creatorcontrib><creatorcontrib>Jelińska, A.</creatorcontrib><creatorcontrib>Zając, M.</creatorcontrib><creatorcontrib>Sobczak, M.</creatorcontrib><creatorcontrib>Bartold, A.</creatorcontrib><creatorcontrib>Oszczapowicz, I.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pharmaceutical and biomedical analysis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cielecka-Piontek, J.</au><au>Jelińska, A.</au><au>Zając, M.</au><au>Sobczak, M.</au><au>Bartold, A.</au><au>Oszczapowicz, I.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A comparison of the stability of doxorubicin and daunorubicin in solid state</atitle><jtitle>Journal of pharmaceutical and biomedical analysis</jtitle><addtitle>J Pharm Biomed Anal</addtitle><date>2009-11-01</date><risdate>2009</risdate><volume>50</volume><issue>4</issue><spage>576</spage><epage>579</epage><pages>576-579</pages><issn>0731-7085</issn><eissn>1873-264X</eissn><coden>JPBADA</coden><abstract>The degradation of doxorubicin and daunorubcin in the solid state was studied using an HPLC method with UV detection (LiChrospher RP-18, 5
μm, 250
mm
×
4
mm; mobile phase: acetonitrile-solution A 1:1, v/v (solution A: 2.88
g of laurisulfate sodium and 1.6
ml of phosphoric acid(V) in 1000
ml); flow rate – 1.4
ml
min
−1; UV detection – 254
nm). The degradation of doxorubicin was a first-order reaction depending on the substrate concentration and daunorubicin degraded according to the kinetic model of autocatalysis. The dependence ln
k
i
=
f(1/
T) was described by the equations ln
k
DOX
=
40.0
±
15.6
–
(19804
±
5682) (1/
T) and ln
k
DAU
=
35.9
±
11.3
–
(16581
±
3972) (1/
T) at 76.4% RH. The dependence ln
k
i
=
f(RH%) was described by the equations ln
k
DOX
=
(8.80
±
3.60)
×
10
−2 (RH%)
–
(21.50
±
2.57) and ln
k
DAU
=
(6.63
±
1.22)
×
10
−2 (RH%)
–
(13.35
±
1.68). The thermodynamic parameters (
E
a, Δ
H
≠a
, Δ
S
≠a
) of the degradation of doxorubicin and daunorubicin were calculated. Although the degradation of doxorubicin was slower at increased temperature (353–373
K) and relative air humidity (50.9–90.0%), the differences between the influence of temperature and relative air humidity on the stability doxorubicin and of daunorubicin were not significant.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>19195811</pmid><doi>10.1016/j.jpba.2008.12.029</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0731-7085 |
ispartof | Journal of pharmaceutical and biomedical analysis, 2009-11, Vol.50 (4), p.576-579 |
issn | 0731-7085 1873-264X |
language | eng |
recordid | cdi_proquest_miscellaneous_733574570 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Analysis Analytical, structural and metabolic biochemistry Antibiotics, Antineoplastic - chemistry Biological and medical sciences Chromatography, High Pressure Liquid - methods Daunorubicin Daunorubicin - chemistry Doxorubicin Doxorubicin - chemistry Drug Stability Fundamental and applied biological sciences. Psychology General pharmacology HPLC Humidity Kinetics Medical sciences Pharmacology. Drug treatments Solid State Spectrophotometry, Ultraviolet - methods Stability Temperature Thermodynamics |
title | A comparison of the stability of doxorubicin and daunorubicin in solid state |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T01%3A46%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20comparison%20of%20the%20stability%20of%20doxorubicin%20and%20daunorubicin%20in%20solid%20state&rft.jtitle=Journal%20of%20pharmaceutical%20and%20biomedical%20analysis&rft.au=Cielecka-Piontek,%20J.&rft.date=2009-11-01&rft.volume=50&rft.issue=4&rft.spage=576&rft.epage=579&rft.pages=576-579&rft.issn=0731-7085&rft.eissn=1873-264X&rft.coden=JPBADA&rft_id=info:doi/10.1016/j.jpba.2008.12.029&rft_dat=%3Cproquest_cross%3E733574570%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733574570&rft_id=info:pmid/19195811&rft_els_id=S0731708508006560&rfr_iscdi=true |